HETEROCYCLIC AMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS
申请人:Wrobleski Stephen T.
公开号:US20080171741A1
公开(公告)日:2008-07-17
A compound of Formula I
and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase.
Heterocyclic Amide Compounds Useful as Kinase Inhibitors
申请人:Bristol-Myers Squibb Company
公开号:EP2468717A1
公开(公告)日:2012-06-27
A compound of Formula I
and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase.
式 I 的化合物
及其对映体、非对映体和药学上可接受的盐。还公开了含有式 I 化合物的药物组合物,以及治疗与 p38 激酶活性相关的病症的方法。
US7935696B2
申请人:——
公开号:US7935696B2
公开(公告)日:2011-05-03
US8404689B2
申请人:——
公开号:US8404689B2
公开(公告)日:2013-03-26
[EN] HETEROCYCLIC AMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSÉS D'AMIDE HÉTÉROCYCLIQUE UTILES COMME INHIBITEURS DE KINASE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2008057775A2
公开(公告)日:2008-05-15
[EN] A compound of Formula I and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase. [FR] L'invention concerne un composé de la formule I et des énantiomères, des diastéréomères et des sels pharmaceutiquement acceptables de ceux-ci. Des compositions pharmaceutiques contenant des composés de la formule I et des procédés de traitement de conditions associées à l'activité de la kinase P38 sont également décrits.